3 recalls found for Ajanta Pharma Ltd. — April 2026.
The recalls listed below are all active notices associated with Ajanta Pharma Ltd. in the FDA, NHTSA, USDA, and CPSC databases. A recall notice may cover specific lot numbers, model numbers, or production date ranges — check each notice carefully to determine whether your specific product is affected.
If you own a recalled product, stop using it and follow the instructions in the official notice for a refund, replacement, or free repair. Vehicle recall repairs are always free regardless of warranty status. For food and consumer products, most retailers will accept returns even without a receipt.
Ajanta Pharma Ltd.
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
Ajanta Pharma Ltd.
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
Ajanta Pharma Ltd.
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.